Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Get Free Report)'s share price rose 0.4% during trading on Friday . The company traded as high as $11.16 and last traded at $11.15. Approximately 50,048 shares were traded during trading, an increase of 48% from the average daily volume of 33,789 shares. The stock had previously closed at $11.10.
Aimei Health Technology Trading Up 0.4%
The business has a fifty day moving average of $11.12 and a 200 day moving average of $10.97.
Hedge Funds Weigh In On Aimei Health Technology
Hedge funds and other institutional investors have recently bought and sold shares of the company. Polar Asset Management Partners Inc. purchased a new position in shares of Aimei Health Technology in the 1st quarter valued at about $110,000. Harraden Circle Investments LLC purchased a new position in shares of Aimei Health Technology in the 4th quarter valued at about $1,117,000. Quarry LP purchased a new position in shares of Aimei Health Technology in the 4th quarter valued at about $1,605,000. Centiva Capital LP boosted its stake in shares of Aimei Health Technology by 1.4% in the 4th quarter. Centiva Capital LP now owns 232,693 shares of the company's stock valued at $2,460,000 after buying an additional 3,100 shares during the period. Finally, Berkley W R Corp purchased a new position in shares of Aimei Health Technology in the 4th quarter valued at about $4,750,000. 45.58% of the stock is currently owned by hedge funds and other institutional investors.
About Aimei Health Technology
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Featured Articles
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
